Panacea Biotec has secured a $20 million long-term loan from the US International Development Finance Corporation to expand its hexavalent ...

Pentavalent vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections cau...

Delta Corp, GM Breweries, Trident Texofab, Supreme Infrastructure, Gujarat Hotels and Choksi Imaging are among the companies that will anno...

The vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections caused by H...

The vaccine protects children against five deadly diseases, including diphtheria, tetanus and hepatitis B. "Panacea Biotec... has received ...

Panacea's product is equivalent to Merck & Co's Maxalt-MLT tablets. The drug has annual sales for around USD 60 million in the US market.

Panacea Biotec today posted a net profit of Rs 82.79 crore for the third quarter ended December 31, 2013.

Panacea Biotec is hopeful of resuming supplies of its pentavalent vaccine 'Easyfive TT', which prevents Tetanus and Hepatitis B.

It is a capital-intensive business where companies require upfront payments to fund R&D activities, says Dr Rajesh Jain, joint managing dir...

Panacea Biotec said on Wednesday that the World Health Organisation (WHO) has found no link between the company’s five-in-one vaccine and d...

Shantha Biotech is recalling several lots of its 24 million five-in-one vaccines globally after WHO found it unsuitable for use.

Stocks are likely to extend gains on Tuesday after crude oil slid to a 14-week low, easing inflation concerns.

Panacea Biotec is learnt to have bagged a $35-million drug supply order from UNICEF to supply pentavalent vaccines, the first Indian compan...

The government has decided not to revive the four state-owned vaccine units whose licences were recently suspended.

Panacea Biotec Ltd has entered into an agreement with Family Vaccines of Philippines to provide access to value added combination vaccines ...